Free Trial

Artelo Biosciences (ARTL) SEC Filings & 10K Form

Artelo Biosciences logo
$13.76 -0.98 (-6.65%)
Closing price 07/24/2025 04:00 PM Eastern
Extended Trading
$13.88 +0.12 (+0.84%)
As of 08:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Artelo Biosciences SEC Filings

DateFilerForm TypeView
07/18/2025
3:35 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 424B5
07/18/2025
3:35 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
11:15 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form EFFECT
07/11/2025
4:26 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/11/2025
3:36 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
7:00 AM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
4:10 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
3:30 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
7:22 AM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
3:24 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
3:11 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
5:06 AM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
7:00 AM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/23/2024
3:01 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
EMANUELE ROBERT MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
Reyes Gregory (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:02 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
Blayney Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:02 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
MATSUI CONNIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:00 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
FAVORITO TAMARA A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
Artelo Biosciences (Issuer)
ARTELO BIOSCIENCES, INC. (Issuer)
Kelly Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:45 PM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:06 AM
Artelo Biosciences (Filer)
ARTELO BIOSCIENCES, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ARTL) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners